Presbia PLC Company Profile (NASDAQ:LENS)

About Presbia PLC (NASDAQ:LENS)

Presbia PLC logoPresbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company's segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company's lens, referred to as the microlens, is a miniature lens designed to be surgically implanted in a patient's eye to improve that patient's ability to see objects at close distances. The microlens is a disc shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia and a central zone that is designed to improve distance vision. The Company's solution is a standalone solution for plano presbyopes, or those individuals suffering from presbyopia but do not have any other visual disorders.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:LENS
  • CUSIP: N/A
  • Web:
  • Market Cap: $68.49 million
  • Outstanding Shares: 17,122,000
Average Prices:
  • 50 Day Moving Avg: $2.98
  • 200 Day Moving Avg: $2.98
  • 52 Week Range: $2.71 - $4.97
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -10.00
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $13,000.00
  • Price / Sales: 5,268.31
  • Book Value: $0.64 per share
  • Price / Book: 6.25
  • EBIDTA: ($16,760,000.00)
  • Return on Equity: -150.69%
  • Return on Assets: -124.10%
  • Debt-to-Equity Ratio: 0.04%
  • Current Ratio: 5.03%
  • Quick Ratio: 4.92%
  • Average Volume: 20,800 shs.
  • Beta: 0.09
  • Short Ratio: 0.9

Frequently Asked Questions for Presbia PLC (NASDAQ:LENS)

What is Presbia PLC's stock symbol?

Presbia PLC trades on the NASDAQ under the ticker symbol "LENS."

How were Presbia PLC's earnings last quarter?

Presbia PLC (NASDAQ:LENS) released its quarterly earnings results on Friday, August, 12th. The company reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.25) by $0.07. The firm had revenue of $0.01 million for the quarter, compared to analyst estimates of $0.04 million. View Presbia PLC's Earnings History.

When will Presbia PLC make its next earnings announcement?

Presbia PLC is scheduled to release their next quarterly earnings announcement on Friday, November, 3rd 2017. View Earnings Estimates for Presbia PLC.

Where is Presbia PLC's stock going? Where will Presbia PLC's stock price be in 2017?

3 equities research analysts have issued 12-month price objectives for Presbia PLC's shares. Their predictions range from $12.00 to $12.00. On average, they anticipate Presbia PLC's stock price to reach $12.00 in the next twelve months. View Analyst Ratings for Presbia PLC.

Who are some of Presbia PLC's key competitors?

Who are Presbia PLC's key executives?

Presbia PLC's management team includes the folowing people:

  • Ralph H. Thurman, Executive Chairman of the Board
  • Todd Cooper, President, Chief Executive Officer, Director
  • Jarett Fenton, Chief Financial Officer, Secretary
  • John Strobel, Vice President of Sales
  • Gerd Auffarth M.D., Ph.D., Director
  • Robert J. Cresci, Director
  • Gerald Farrell Ph.D., Director
  • Vladimir Feingold, Director
  • Zohar Loshitzer, Director

When did Presbia PLC IPO?

(LENS) raised $50 million in an initial public offering (IPO) on Thursday, January 29th 2015. The company issued 4,200,000 shares at a price of $11.00-$13.00 per share. Jefferies acted as the underwriter for the IPO.

Who owns Presbia PLC stock?

Presbia PLC's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (15.15%) and Vanguard Group Inc. (0.37%). Company insiders that own Presbia PLC stock include Gerald Farrell, Randy H Thurman, Richard Fogarty, Richard S Ressler, Robert J Cresci, Todd Cooper and Zohar Loshitzer. View Institutional Ownership Trends for Presbia PLC.

Who sold Presbia PLC stock? Who is selling Presbia PLC stock?

Presbia PLC's stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc.. View Insider Buying and Selling for Presbia PLC.

Who bought Presbia PLC stock? Who is buying Presbia PLC stock?

Presbia PLC's stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC. Company insiders that have bought Presbia PLC stock in the last two years include Gerald Farrell, Randy H Thurman, Richard Fogarty, Richard S Ressler, Robert J Cresci, Todd Cooper and Zohar Loshitzer. View Insider Buying and Selling for Presbia PLC.

How do I buy Presbia PLC stock?

Shares of Presbia PLC can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Presbia PLC's stock price today?

One share of Presbia PLC stock can currently be purchased for approximately $4.00.

MarketBeat Community Rating for Presbia PLC (NASDAQ LENS)
Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  51 (Vote Outperform)
Underperform Votes:  64 (Vote Underperform)
Total Votes:  115
MarketBeat's community ratings are surveys of what our community members think about Presbia PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Presbia PLC (NASDAQ:LENS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.00 (200.00% upside)

Analysts' Ratings History for Presbia PLC (NASDAQ:LENS)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/23/2017HC WainwrightReiterated RatingBuy$12.00LowView Rating Details
5/22/2017Rodman & RenshawLower Price TargetBuy -> Buy$14.00 -> $12.00MediumView Rating Details
10/4/2016Jefferies Group LLCUpgradeMarket Perform -> Market OutperformN/AView Rating Details
(Data available from 9/22/2015 forward)


Earnings History for Presbia PLC (NASDAQ:LENS)
Earnings by Quarter for Presbia PLC (NASDAQ:LENS)
Earnings History by Quarter for Presbia PLC (NASDAQ LENS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/12/2016Q3 2016($0.25)($0.32)$0.04 million$0.01 millionViewN/AView Earnings Details
3/25/2016Q2($0.26)($0.29)$0.04 million$0.03 millionViewN/AView Earnings Details
8/6/2015Q2 2015($0.29)($0.40)$0.40 million$0.04 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Presbia PLC (NASDAQ:LENS)
Current Year EPS Consensus Estimate: $-0.69 EPS
Next Year EPS Consensus Estimate: $-0.4 EPS


Dividend History for Presbia PLC (NASDAQ:LENS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Presbia PLC (NASDAQ:LENS)
Insider Ownership Percentage: 74.70%
Institutional Ownership Percentage: 16.50%
Insider Trades by Quarter for Presbia PLC (NASDAQ:LENS)
Institutional Ownership by Quarter for Presbia PLC (NASDAQ:LENS)
Insider Trades by Quarter for Presbia PLC (NASDAQ:LENS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/17/2016Gerald FarrellDirectorBuy5,000$4.65$23,250.00View SEC Filing  
12/17/2015Richard S ResslerDirectorBuy500$6.00$3,000.00View SEC Filing  
12/10/2015Richard S. ResslerDirectorBuy499$6.00$2,994.00View SEC Filing  
12/2/2015Richard S. ResslerDirectorBuy1,300$5.86$7,618.00View SEC Filing  
11/25/2015Randy H ThurmanChairmanBuy1,833$5.45$9,989.85View SEC Filing  
11/24/2015Richard S ResslerDirectorBuy2,300$4.97$11,431.00View SEC Filing  
11/20/2015Richard FogartyCAOBuy1,000$4.00$4,000.00View SEC Filing  
11/19/2015Robert J. CresciDirectorBuy10,000$3.97$39,700.00View SEC Filing  
11/19/2015Zohar LoshitzerInsiderBuy5,500$4.00$22,000.00View SEC Filing  
11/18/2015Todd CooperCEOBuy7,500$3.99$29,925.00View SEC Filing  
5/26/2015Richard FogartyCAOBuy1,000$8.60$8,600.00View SEC Filing  
5/20/2015Randy H ThurmanChairmanBuy11,110$8.96$99,545.60View SEC Filing  
2/3/2015Richard S ResslerDirectorBuy500,000$10.00$5,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Presbia PLC (NASDAQ:LENS)
Latest Headlines for Presbia PLC (NASDAQ:LENS)
DateHeadline logoHead to Head Survey: Presbia PLC (LENS) vs. The Competition - September 20 at 2:22 PM logoAnalyzing Presbia PLC (LENS) & The Competition - September 16 at 4:24 AM logoPresbia to Participate in Rodman & Renshaw 19th Annual Global Investment Conference - September 8 at 1:16 AM logoPresbia PLC (LENS) Rating Increased to Sell at ValuEngine - September 2 at 11:14 PM logoETFs with exposure to Presbia Plc : August 1, 2017 - August 2 at 3:04 AM logoETFs with exposure to Presbia Plc : July 3, 2017 - July 3 at 7:51 PM logoETFs with exposure to Presbia Plc : June 19, 2017 - June 19 at 5:17 PM logoComparing Entellus Medical (ENTL) and Presbia PLC (LENS) - June 17 at 10:44 AM logoETFs with exposure to Presbia Plc : June 5, 2017 - June 5 at 6:59 PM logoPresbia Plc :LENS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 - June 2 at 7:40 PM logoPresbia to Participate in Jefferies 2017 Global Healthcare Conference - May 31 at 5:31 AM logoPresbia PLC (LENS) Earns Buy Rating from HC Wainwright - May 28 at 7:24 AM logoPresbia PLC (LENS) Cut to Sell at Zacks Investment Research - May 25 at 12:38 AM logoRodman & Renshaw Lowers Presbia PLC (LENS) Price Target to $12.00 - May 22 at 8:16 AM logoPresbia to Participate in the 2017 ASCRS Symposium & Congress in Los Angeles, California - May 3 at 10:24 PM logoPresbia PLC (LENS) Earning Somewhat Negative News Coverage, Report Shows - May 3 at 12:14 PM logo Brokerages Expect Presbia PLC (LENS) Will Announce Earnings of -$0.15 Per Share - May 3 at 12:04 AM logoPresbia PLC (LENS) Given Daily Media Sentiment Rating of -0.10 - April 30 at 8:22 AM logoPresbia PLC (LENS) Receiving Somewhat Negative Press Coverage, Report Finds - April 25 at 1:24 PM logoPresbia PLC (LENS) Getting Somewhat Negative Media Coverage, Report Finds - April 17 at 9:13 AM logoZacks: Brokerages Anticipate Presbia PLC (LENS) Will Post Earnings of -$0.15 Per Share - April 11 at 6:04 PM logoShort Interest in Presbia PLC (LENS) Decreases By 32.5% - April 10 at 4:16 PM logoZacks: Brokerages Set $12.50 Target Price for Presbia PLC (LENS) - April 4 at 12:01 AM logo6:15 pm Presbia extends shareholder rights offering for up to 4.5 mln ordinary shares to March 8 from February 23 - February 23 at 11:16 PM logoPRESBIA PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits - February 22 at 6:24 PM logoPresbia Announces Extension of Rights Offering - February 22 at 6:24 PM logoForm 424B4 Presbia PLC - January 27 at 8:27 PM logoPresbia Announces Price and Key Dates Related to Rights Offering - January 26 at 8:01 PM logo5:00 pm Presbia announces the key dates relative to its rights offering - January 26 at 8:01 PM logoPresbia PLC (LENS) Looks Good: Stock Adds 8.2% in Session - December 6 at 10:15 AM logoPresbia to Participate in the 2016 Aegis Capital Growth Conference - September 20 at 11:01 AM logoPresbia to Participate in the Rodman & Renshaw 18th Annual Healthcare Conference - September 7 at 9:25 AM logoPresbia to Participate in the 2016 Baird Global Health Conference - September 1 at 8:58 AM logoPresbia (LENS) Unit Completes Acquisition of Neoptics AG - August 22 at 10:31 AM logoPRESBIA PLC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders - August 10 at 8:54 AM logoPRESBIA PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition - August 8 at 6:09 PM logoCombined Cataract and Presbia Microlens Surgeries Demonstrate Excellent Results and Patient Satisfaction in Near-Vision Improvement - July 18 at 8:00 AM logoPresbia to Participate in the 2016 Australasian Society of Cataract and Refractive Surgeons 20 th Annual Conference - July 12 at 10:20 AM logoTop U.S. LASIK Surgeon Supports Presbia’s Microlens as Solution to Near-Vision - June 2 at 8:00 AM logoHere's Why Presbia Is Worth $14/Share, Despite Plummeting Monday - May 23 at 1:49 PM logoRodman & Renshaw Initiates 'Unsung' Presbia With Buy; Stock Jumps - May 10 at 2:56 PM logoCoverage initiated on Presbia by Rodman & Renshaw - May 10 at 7:07 AM logoPRESBIA PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits - May 2 at 5:05 PM logoPRESBIA PLC Files SEC form 10-K, Annual Report - March 28 at 6:03 AM logoFirst Patients in Presbia Microlens FDA Study Complete 12-Month Postoperative Visits - March 1 at 8:00 AM



Presbia PLC (LENS) Chart for Friday, September, 22, 2017

This page was last updated on 9/22/2017 by Staff